Registration - Amendment
ML STRATEGIES, LLC for ASTELLAS PHARMA US, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 1082 Food and Drug Administration Revitalization Act H. R. 2900 Food and Drug Administration Amendment Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID LEITER New | — |
| ROBERT NEAL MARTIN New | — |
| JEREMY RABINOVITZ New | Chief of Staff for Congresswoman L. Capps |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ASTELLAS PHARMA, INC. | Japan | Japan | 99.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.